Literature DB >> 12871776

Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer.

Irene Pino1, Rubén Pío, Gemma Toledo, Natalia Zabalegui, Silvestre Vicent, Natalia Rey, María D Lozano, Wenceslao Torre, Jesús García-Foncillas, Luis M Montuenga.   

Abstract

hnRNP A2/B1 has been suggested as a useful early detection marker for lung carcinoma. hnRNP A2/B1 is a member of a large family of heterogeneous nuclear ribonucleoproteins (hnRNP proteins) involved in a variety of functions, including regulation of transcription, mRNA metabolism, and translation. In lung cancer, we have evaluated the expression and cellular localization of several members of the hnRNP family, hnRNP A1, A2, B1, C1, C2 and K. 16 cell lines (SCLC and NSCLC) and biopsies from 32 lung cancer patients were analyzed. Our results suggest that, besides hnRNP A2/B1, the expression of other members of the hnRNP family is altered both in SCLC and NSCLC. In the biopsies, negative or low expression of the hnRNP proteins analyzed was observed in normal epithelial cells whereas lung cancer cells showed highly intense nuclear or cytoplasmic immunolocalization. In all the lung cancer cell lines, the mRNA for all the hnRNP proteins was detected. In general, higher levels of hnRNP mRNAs were found in SCLC as compared with NSCLC. Our results also suggest that the expression and processing of each hnRNP protein in lung cancer is independently regulated and is not exclusively related to proliferation status. In SCLC cell lines, hnRNP A1 protein expression correlated with that of Bcl-x(L). In the lung cancer cell lines, hnRNP K protein localization varied with the cellular confluence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871776     DOI: 10.1016/s0169-5002(03)00193-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  49 in total

1.  Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins.

Authors:  Mo Chen; Charles J David; James L Manley
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

2.  In vivo identification of ribonucleoprotein-RNA interactions.

Authors:  Jennifer Zielinski; Kalle Kilk; Tiina Peritz; Theresa Kannanayakal; Kevin Y Miyashiro; Emelía Eiríksdóttir; Jeanine Jochems; Ulo Langel; James Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

Review 4.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

5.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

Authors:  Renyuan Zhou; Reneé Shanas; Mark A Nelson; Achyut Bhattacharyya; Jiaqi Shi
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

6.  Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.

Authors:  Ruben Pio; David Blanco; Maria Jose Pajares; Elena Aibar; Olga Durany; Teresa Ezponda; Jackeline Agorreta; Javier Gomez-Roman; Miguel Angel Anton; Angel Rubio; Maria D Lozano; Jose M López-Picazo; Francesc Subirada; Tamara Maes; Luis M Montuenga
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

7.  Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter.

Authors:  Michal Mikula; Pawel Gaj; Karolina Dzwonek; Tymon Rubel; Jakub Karczmarski; Agnieszka Paziewska; Artur Dzwonek; Piotr Bragoszewski; Michal Dadlez; Jerzy Ostrowski
Journal:  DNA Res       Date:  2010-06-29       Impact factor: 4.458

8.  Role of nitric oxide and its metabolites as potential markers in lung cancer.

Authors:  Fares Masri
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

9.  Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.

Authors:  Chia-Chen Ko; Yun-Ju Chen; Chih-Ta Chen; Yu-Chih Liu; Fong-Chi Cheng; Kai-Chao Hsu; Lu-Ping Chow
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

10.  Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

Authors:  P Barboro; E Repaci; A Rubagotti; S Salvi; S Boccardo; B Spina; M Truini; C Introini; P Puppo; N Ferrari; G Carmignani; F Boccardo; C Balbi
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.